martes, 6 de octubre de 2026
BuscarExplore
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· January 8, 2026

Britain’s biggest weapons maker surges after Trump military pledge

View original at uk.finance.yahoo.com
Britain’s biggest weapons maker surges after Trump military pledge Shares in UK weapons maker BAE Systems surged after Donald Trump vowed to boost military spending - Lorne Campbell/Guzelian UK-listed defence stocks surged after Donald Trump vowed to ramp up military spending after his capture of Venezuelan leader Nico…
Opening lines of the source · short snapshot — read the full document at the original

Lo que extrajimos de esta fuente

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Russia's shadow fleet tripled since late 2022

    80% confidence
  • North Korea and Iran have used shadow fleets to evade UN sanctions for almost two decades

    80% confidence
  • Markets pricing in faster and larger increases in European defence spending, stronger domestic arms production and a renewed push for strategic autonomy

    80% confidence
  • Labour reforms could cost commercial landlords £11bn and cause 15% property price slump

    80% confidence
  • Military equipment is not being made fast enough

    80% confidence
  • US inflation December 2025 will be 3% (from 2.7% November), ending 2026 at 3.2%

    80% confidence
  • US unemployment 2026 average will be 4.6%

    80% confidence
  • Starmer and EU should stop histrionics over Greenland threats

    80% confidence
  • European defense stocks offer long-term value despite 20-40% decline since September; paradigmatic realignment in EU/Nato/UK defence policy

    80% confidence
  • Fed will cut rates twice in 2026 H1, from 3.75%-3.5% range to 3.25%-3% range (faster than market expects October for second cut)

    80% confidence
  • US will not allow Venezuela to become a client state of China

    80% confidence
  • Effective tariff rate in October was close to 14%

    80% confidence
  • Trump move toward government intervention would create uncertainty and add to some risk premium

    80% confidence
  • As long as America is the dominant force in Venezuela with rule of law, US controls oil flow and that will be fine

    80% confidence
  • There is a window of opportunity for Greenland independence from Denmark

    80% confidence
  • Enforcement typically lags rhetoric on sanctions

    80% confidence
  • Greenland's future is for Denmark/Greenland to decide

    80% confidence
  • Shadow fleet accounts for 20% of global crude transport ships

    80% confidence
  • US will rebuild Venezuela in a very profitable way using oil revenue and will run it much longer than 3-6 months

    80% confidence
  • In 2026, trade could be negligible for growth overall

    80% confidence
  • Sterling doing really quite well after Budget correction

    80% confidence
  • US will run Venezuela much longer than 3-6 months

    80% confidence
  • Gold/silver under pressure from ~$6-7bn selling on Comex futures due to Bloomberg Commodity Index rebalance

    80% confidence
  • Market has ignored geopolitical risks and focused on the fundamentals

    80% confidence
  • Oil price forecast for 2026 is $50/barrel

    80% confidence
  • Chevron expected to quickly grow US oil operations in Venezuela; ConocoPhillips and Exxon Mobil looking to play role

    80% confidence
  • US GDP growth 2025 will be 2.1% (revised up from 1.8%)

    80% confidence
  • Declining US imports show ongoing negative economic impact of tariffs

    80% confidence

Data points we hold from this source

NASDAQ · index level23548.88 points
Lo que sabemos · la inteligencia detrás de esta página
En vivo desde el sustrato
Lo que estamos viendo
Obesity and Immunology Readouts, Big Pharma M&A and AI-Designed Drugs Converge Into a Q4 2026 Catalyst Wave
Late-stage data and deal activity are clustering ahead of Q4 2026. Novo Nordisk's CagriSema won Best Abstract at EASD 2026 for its brain and body (fMRI/MRI) data, Lilly showed ADtouch results for EBGLYSS and agreed to buy Merida Biosciences for $2.9B, and Merck's tulisokibart hit its Phase 2b endpoints. A key regulatory catalyst follows: the FDA PDUFA date for the ivonescimab BLA on 2026-11-14. AI-designed rentosertib showing anti-aging effects adds a speculative AI-drug-discovery thread, while QAIAx's microcities trial and QIII pilot (planned 2027-01-01) are peripheral, forecast-only items.
Nuestra lectura de los datos ›
Señales que seguimos
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patrones que observamos ›
Donde las fuentes discrepan
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
Señalamos los conflictos abiertamente ›
Verificado recientemente
✓ Verificado con la fuente original
4,985
hechos rastreados a su fuente — y señalamos los que no se sostienen.
101 entidades seguidas4,985 hechos verificados con la fuente5,351 documentos fuente archivados
Consulta estos datos → isubstrate.com
Britain’s biggest weapons maker surges after Trump military pledge — Source | Via News | es.VIA.NEWS